Bayrak Ayse Cigdem, Fadiloglu Erdem, Tuncer Haticegul, Kir Edip Alptug, Kayikci Umutcan, Deren Ozgur
Hacettepe University Faculty of Medicine Department of Obstetrics and Gynecology Division of Maternal Fetal Medicine Ankara Turkey Hacettepe University Faculty of Medicine, Department of Obstetrics and Gynecology, Division of Maternal Fetal Medicine, Ankara, Turkey.
Rev Bras Ginecol Obstet. 2025 Apr 30;47. doi: 10.61622/rbgo/2025rbgo17. eCollection 2025.
This retrospective study aimed to investigate blood-based immune-inflammatory biomarkers (IIBs) in predicting neonatal outcomes in pregnancies with pregestational diabetes mellitus (PGDM).PIV[(neutrophil×platelet×monocyte)/lymphocyte)], SII (neutrophil×platelet/lymphocyte), and NLR neutrophil/lymphocyte) values were evaluated in all three trimesters, and their correlation with neonatal outcomes was examined.
We included 82 cases of PGDM pregnancies delivered after 32 weeks. Maternal age, gravidity, parity, types of diabetes, and route of delivery were noted. For neonatal outcomes, we recorded gestational age at birth, birth weight percentile, existence of fetal growth restriction, LGA, neonatal intensive care unit (NICU) requirement, Apgar Score <7 at 1, 5, or 10 minutes, need for positive pressure ventilation (PPV), need for mechanical ventilation, hypoglycaemia, hyperbilirubinemia and the need for phototherapy. PIV, SII and NLR values were calculated in each trimester and their association with adverse neonatal outcomes was analyzed.
We could not detect any consistent and significant correlation between SII and PIV values and adverse neonatal outcomes for each trimester. There was a correlation between 3rd trimester NLR and adverse neonatal outcomes, including APGAR <7, the requirement for PPV and mechanical ventilation (p=0.056, 0.013 and 0.060, respectively).
While SII and PIV values did not consistently correlate with adverse neonatal outcomes throughout each trimester in PGDM pregnancies, 3rd-trimester NLR showed a notable association with the requirement for PPV with statistical significance and with Apgar Score <7 and the requirement for mechanical ventilation without statistical significance. NLR in the third trimester may hold potential as a predictive marker for specific adverse neonatal outcomes in PGDM pregnancies, warranting further investigation.
本回顾性研究旨在探讨基于血液的免疫炎症生物标志物(IIB)在预测孕前糖尿病(PGDM)妊娠新生儿结局中的作用。在孕三个阶段评估血小板-免疫细胞比(PIV,即中性粒细胞×血小板×单核细胞/淋巴细胞)、全身免疫炎症指数(SII,即中性粒细胞×血小板/淋巴细胞)和中性粒细胞与淋巴细胞比值(NLR),并检测它们与新生儿结局的相关性。
我们纳入了82例孕32周后分娩的PGDM妊娠病例。记录产妇年龄、孕次、产次、糖尿病类型和分娩方式。对于新生儿结局,我们记录出生时的胎龄、出生体重百分位数、胎儿生长受限情况、大于胎龄儿情况、新生儿重症监护病房(NICU)需求、1分钟、5分钟或10分钟时阿氏评分<7、正压通气(PPV)需求、机械通气需求、低血糖、高胆红素血症以及光疗需求。在每个孕期计算PIV、SII和NLR值,并分析它们与不良新生儿结局的关联。
我们未发现SII和PIV值与各孕期不良新生儿结局之间存在任何一致且显著的相关性。孕晚期NLR与不良新生儿结局之间存在相关性,包括阿氏评分<7、PPV需求和机械通气需求(p值分别为0.056、0.013和0.060)。
虽然在PGDM妊娠的每个孕期中,SII和PIV值与不良新生儿结局之间没有始终如一的相关性,但孕晚期NLR与PPV需求具有显著统计学关联,与阿氏评分<7和机械通气需求无统计学意义的关联。孕晚期NLR可能作为PGDM妊娠特定不良新生儿结局的预测标志物,值得进一步研究。